The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout
The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout

Chinese Covid-19 vaccine gets UAE nod for therapeutic use trial

  • Approval follows earlier green light in the UAE and New Zealand for preventive use trials of YishengBio vaccine
  • Patients with mild to moderate Covid-19 infections will be targeted first in trial of regimen involving two shots seven days apart

The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout
The YishengBio recombinant vaccine, approved for both preventive and therapeutic use trials by the UAE, involves an independently developed adjuvant. Photo: Handout
READ FULL ARTICLE